Teladoc Health shares rose nearly 6% after the company announced its acquisition of preventative care provider Catapult Health in an all-cash $65 million deal. The move aims to enhance Teladoc’s ability to detect health conditions early and expand its services in integrated care.
Catapult Health offers at-home wellness exams, enabling users to check blood pressure, collect blood samples, and complete screenings before meeting virtually with a nurse practitioner. Teladoc plans to integrate Catapult’s services into its existing virtual care platform, improving preventative health offerings and helping members access convenient wellness care.
CEO Chuck Divita emphasized the strategic value of the acquisition, stating that Catapult’s capabilities will increase access to preventative healthcare while creating more value for Teladoc customers. Catapult serves around 3 million members, while Teladoc has a membership base of over 93 million. In the third quarter of 2024, Catapult generated $30 million in revenue.
Catapult CEO David Michel highlighted the potential impact of the merger, noting that joining Teladoc will accelerate innovation and support their shared mission of empowering healthier lives. The deal is expected to close in Q1 of this year.
This acquisition comes as Teladoc navigates a challenging period, following its high-profile acquisition of Livongo in 2020, which had a combined enterprise value of $37 billion at the time. Since then, Teladoc’s market cap has fallen below $2 billion, reflecting the broader slowdown in digital health growth.
The company also underwent leadership changes, with former CEO Jason Gorevic stepping down in April 2024 after leading the company through the Livongo merger and Covid-19 pandemic. Divita took over as CEO in June, pledging to position Teladoc for long-term, sustainable success.
The Catapult acquisition may indicate a trend toward consolidation in the digital health sector, as companies shift focus to profitability and sustainable growth. In January, Transcarent announced plans to acquire Accolade for $621 million, reinforcing the need for strategic mergers in the evolving healthcare landscape.
With expanding preventative care services and a renewed focus on growth, Teladoc is positioning itself for a stronger future, adapting to the changing demands of virtual healthcare.
READ MORE: